skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

What is Citeline?

Clinical R and D

Citeline is the industry’s most comprehensive, reliable and current global R&D intelligence suite of solutions. Built by experts, made for experts, Citeline solutions transform data into knowledge. And now our new, next generation platform delivers unparalleled access to Citeline’s robust clinical trial intelligence. With greater ease, speed and efficiency than ever before, Citeline’s next generation platform will help you gain critical insights into the global clinical trial landscape and realize greater cost-savings as you develop on your clinical trial programs.

What Citeline does: 

Citeline organizes vast quantities of data with human intelligence to greatly reduce research time, clinical trial costs and optimize trial outcomes. It features an unmatched collection of critical information on global clinical trials, investigators and sites, and drug development pipelines all with direct expert analyst support. Stay updated on what your competitors are doing with full public domain coverage of over 40,000 sources, continuous updating and full record reviews, advanced indexing and proprietary content.

Gain key insights that can be turned into actionable results with unparalleled access to 265,000+ clinical trials, 400,000 investigators, 68,000+ drugs, 117,000+ sites, 235+ diseases in 8 major therapeutic areas across 166 countries. And our 250+ therapeutic area experts and analysts are dedicated to provide the support needed so that you’re getting the most appropriate data to meet your requirements.

Citeline solutions:


If you are a Citeline subscriber, please access your login here.

Related products


Sitetrove: 治験責任医師と治験施設情報のデータベース

Sitetrove(サイトトローブ)は、170か国・40万人以上の治験責任医師(PI: Principal Investigator)と235以上の疾患に対応する11万7千か所以上の治験施設に関する情報を収録するデータベースです。治験責任医師と治験施設に関して業界で最も正確で包括的な情報を提供することで、コスト増につながる治験の遅延を最小化し、お客様の臨床試験を成功に導くようサポートします。Sitetroveに登録される治験責任医師は、豊富な臨床経験や治験に関する十分な知識をもっていることをアナリストにより精査されています。

Key benefits:

  • 治験責任医師と治験施設情報のデータベース
  • 疫学ダッシュボードは見やすいマップビュー
  • Ask-the-Analyst機能で情報に基づく意思決定
trial-trove-pharma intelligence

Trialtrove: 医療用医薬品の臨床試験情報データベース


Key benefits:

  • 専門家による情報精査
  • 世界中の臨床試験情報を網羅
  • 標準治療に関する情報
pharma intelligence pharma banner

Pharmaprojects: 医薬品開発パイプラインのデータベース


Key benefits:

  • 医療用医薬品の研究・開発パイプライン情報
  • 35年間にわたる過去のヒストリカルデータも
  • Ask-the-Analyst機能で情報に基づく意思決定
Citeline analytics

Citeline Analytics

Citeline’s Custom Analytics service provides expert analytical and project-orientated support for your strategic business questions.

Key benefits:

  • Actionable intelligence
  • Expert Analysis
  • Tailored solutions


  • Trialtrove: 医療用医薬品の臨床試験情報データベース, Medtrack: 製薬企業などヘルスケア企業情報のデ...


    23 Oct 2019


    Topic biopharmaceutical clinical-trials

  • Trialtrove: 医療用医薬品の臨床試験情報データベース


    18 Oct 2019

    2018年に開始された第I相臨床試験~第III相臨床試験を総括する無料ホワイトペーパー「2018 Clinical Trials Roundup: Surveying the Landscape of 2018 Trial Starts(全22頁)」をダウンロードできます。2018年に開始された臨床試験とその競合状況を鳥の目で分析して、バイオ医薬品産業全体のトレンドを明らかにしています。また、個々の企業の戦略や優先課題も考察しています。

    Topic drug-development-landscape biopharmaceutical business-strategies

  • Trialtrove: 医療用医薬品の臨床試験情報データベース

    Trialtrove 2018 Clinical Trials Roundup Surveying the Landscape of 2018 Trial Starts infographic

    11 Oct 2019

    Trialtrove 2018 Clinical Trials Roundup Surveying the Landscape of 2018 Trial Starts infographic

    A clear view of the past is often the surest way to plan for the future. The annual analysis of Phase I-III clinical trials from Citeline’s Trialtrove reveals the priorities and strategies of the biopharma industry. This infographic lets you clearly see the players, trials, and trends.  

    Topic drug-development-landscape biopharmaceutical business-strategies

  • Trialtrove: 医療用医薬品の臨床試験情報データベース

    Trialtrove 2018 Completed Clinical Trials Snapshot

    12 Aug 2019

    Get a visual snapshot of how the industry pipelines are faring with our 2018 Completed Trials snapshot. This graphic analysis paints a clear picture of the state of clinical trial completions, while pointing to some important changes that are emerging.  

    Topic clinical-trials drug-development-landscape

  • Trialtrove: 医療用医薬品の臨床試験情報データベース


    12 Aug 2019

    無料ホワイトペーパー『2018年に終了した臨床試験~製薬企業による臨床開発動向/原題:2018 Completed Trials: State of Industry-Sponsored Clinical Development』が発行されました。インフォーマ・ファーマインテリジェンスでは過去4年に渡って同様のホワイトペーパーを発行してきました。今年も2018年に完了したフェーズI~III/IVまでの合計4,864の臨床試験と開発中止となった762の試験について、19個の図表を用いて解説しています。

    Topic drug-development-landscape

  • Sitetrove: 治験責任医師と治験施設情報のデータベース, Trialtrove: 医療用医薬品の臨床試験情報デー...

    Citeline: Global Clinical Trial Intelligence Solutions

    02 Jul 2019

    Citeline is the industry’s most comprehensive, reliable and up-to-date global clinical trial intelligence suite, designed to help you save time and money by enrolling patients faster. Our team of more than 250 industry experts transform data into knowledge, integrating robust drug, trial, investigator, and site intelligence.

    Topic Clinical trials Clinical trial optimization

  • Trialtrove: 医療用医薬品の臨床試験情報データベース


    25 Jun 2019

    がん臨床試験に対する投資額の効果を探る無料ホワイトペーパー「A Decade in Review: Oncology Trial Benchmarks and Sponsor Analysis」が発行されました。競争が激しくなる中、医薬品業界全体で様々なレベルの投資が行われており、新薬を市場に投入するための平均コストは上昇し続けています。このような投資額の増加は臨床試験の実施状況にどのような影響を与えているのでしょうか。

    Topic clinical-trials cancer

  • Trialtrove: 医療用医薬品の臨床試験情報データベース

    2017 Clinical Trials Roundup The Evolution Continues

    By Doro Shin 15 Jun 2019

    For a detailed look at the statistics and trends surrounding clinical trials initiated in 2017, we invite you to download 2017 Clinical Trials Roundup: The Evolution Continues. Using a wealth of trial data from Trialtrove, this information-packed white paper provides a detailed analysis of Phase I–III clinical trials that were initiated last year.

    Topic clinical-trials

  • Trialtrove: 医療用医薬品の臨床試験情報データベース

    From STEP to PrEP

    By Jonathan Slater 07 Mar 2019

    In June 2016, all United Nations Member States pledged to end the AIDS epidemic as a public health threat by 2030 and signed up to time-bound targets.

    Topic drug-development-landscape diseases

  • Trialtrove: 医療用医薬品の臨床試験情報データベース

    2017 Completed Trials

    19 Oct 2018

    As Informa Pharma Intelligence has done for the past three years, this analysis examines the landscape of industry-sponsored clinical trials completed during 2017, of which there were a total of 3,534 Phase I through Phase III/IV. The nearly 700 trials terminated in 2017 were not included in this analysis.

    Topic clinical-trials

  • Trialtrove: 医療用医薬品の臨床試験情報データベース

    Rheumatoid Arthritis - Old and New Approaches Shifting the Treatment Paradigm

    By Laura Runkel 19 Oct 2018

    Explore the current and future outlook for rheumatoid arthritis (RA) treatments. Such treatments remain ineffective for the 33% of RA sufferers who are or become unresponsive to treatment, resulting in a high interest in RA drug development to address this unmet need in the marketplace.

  • Trialtrove: 医療用医薬品の臨床試験情報データベース

    Sepsis and the Receding Grail

    05 Jan 2018

    Sepsis is a life-threatening illness culminating in multi-organ dysfunction paired with a systemic inflammatory response. The disease burden is considerable: it is the single most expensive condition treated in hospitals, with annual costs in the US projected at nearly $24bn.

  • Trialtrove: 医療用医薬品の臨床試験情報データベース

    Is China the Dark Horse in Clinical Development?

    30 Nov 2017

    Over the last decade, it is undeniable that China has emerged as a rising star in pharmaceutical R&D

    Topic clinical-trials

  • Trialtrove: 医療用医薬品の臨床試験情報データベース

    2016 Clinical Trials Round up Webinar Recording

    25 Sep 2017

    Watch the latest webinar on Clinical Trials

    Topic clinical-trials

  • Trialtrove: 医療用医薬品の臨床試験情報データベース

    Breast cancer PGX biomarker trials leading the way

    09 Aug 2017

    Breast cancer PGX biomarker trials leading the way

    Breast cancer trials are making the most use of personalized medicine developments in trials, according to data gathered by Trialtrove.

    Topic clinical-trials-blog clinical-trials



Susan Danheiser

Management, Director


Susan Danheiser

Susan specializes in

  • Commercial Strategy
  • Clinical Trials
  • Oncology
  • Neurology

+23 year(s) experience




電話:+81 (0)3 6273 4260